Perifit pelvic floor trainer

How a biofeedback pelvic floor trainer works

Perifit pairs a vaginal sensor with a smartphone app that turns pelvic floor exercises into games. Pressure-sensitive sensors detect the force exerted when you contract your muscles. The device does not record electrical muscle signals like an electromyography, or EMG, system, and it does not electrically stimulate the muscles. FDA device description

The silicone-covered probe sends information about your contractions to the app in real time. Squeezing the pelvic floor muscles can, for example, move a character on the screen. This gives you a visible response to an otherwise difficult-to-see movement while you practice Kegel exercises.

Made by X6 Innovations, Perifit belongs to a different category from vaginal weights or electrical stimulation devices. With biofeedback, you make the contraction yourself and receive information about it. Clinicians have long used this approach in rehabilitation, including to help people learn to relax their pelvic floor. Rehabilitation review

Marketing for pelvic floor biofeedback devices commonly emphasizes four potential benefits:

• Fewer symptoms of stress urinary incontinence.
• Support for pelvic floor recovery after childbirth.
• Better sexual well-being and pelvic floor function.
• Better results than unaided Kegel exercises through real-time feedback.

These are different claims, and the evidence supporting one does not automatically establish the others.

The mechanism: pressure sensing, feedback, and regular practice

Perifit functions as a perineometer: its sensor detects changes in force against the probe as you contract and relax. The display makes the exercise visible. It does not provide a complete assessment of pelvic floor strength, coordination, or resting muscle tension.

Whether feedback adds a benefit is a separate question from whether the exercises work. Pelvic floor muscle training, usually shortened to PFMT, can improve urinary incontinence and is a first-line conservative treatment. A high score in the app, however, does not establish that the movement is correct or that symptoms are improving. Cochrane review

Games may make a routine easier to maintain. That is a plausible advantage, but it does not establish that Perifit improves adherence compared with an equally well-supported exercise program. An early study of 24 women found better muscle control and less leakage with intensive clinical biofeedback than with verbal feedback. That procedure was not equivalent to using a home sensor. A 2025 review of adherence found inconsistent measurement methods and no significant between-group difference in incontinence severity. Early trial · Adherence review

The additional contribution of biofeedback beyond PFMT therefore needs careful interpretation. A 2025 Cochrane review covering 41 studies and 3,483 women found little or no meaningful difference in incontinence-related quality of life when biofeedback was added. That result puts a limit on broad claims of superiority without ruling out individual preferences or practical usefulness. Cochrane review

Which specifications matter

Features can help you choose a device, but a longer feature list does not establish a larger treatment effect.

A clear exercise program, a comfortable sensor, and a good match between the device and the cause of your symptoms matter more. Professional guidance is particularly useful if contracting or fully relaxing the muscles is difficult.

• Sensor type. Perifit uses force sensors. Other systems measure pressure or electrical activity with EMG. These methods are not interchangeable, and none provides a complete pelvic floor assessment on its own.
• Training program. The program should allow for contraction, relaxation, and recovery, with an intensity you can tolerate. General recommendations for daily pelvic floor exercise cannot simply be converted into the same number of daily device sessions.
• Regulatory status. The Perifit model described in FDA submission K221476 has US 510(k) clearance for specified urinary incontinence indications. This does not cover every wellness claim a seller might make. FDA documents
• Privacy. Check which training and health information is stored, who can access it, and how you can delete it. Privacy is a selection criterion, not evidence that a treatment works.

Price categories such as entry-level, midrange, or clinical say little about effectiveness. Appropriate instruction and understandable outcomes are more useful comparisons. The authors of the 2024 Perifit study worked for the manufacturer, a conflict of interest that matters when interpreting the results.

Pelvic floor physical therapy can assess symptoms, muscle tension, and movement, then adapt exercises accordingly. An app can support practice but cannot replace that assessment. Any vaginal examination should be explained in advance and performed only with your consent.

What research shows about Perifit and pelvic floor training

The evidence falls into five areas: stress urinary incontinence, the additional contribution of biofeedback, recovery after childbirth, results specific to Perifit, and sexual well-being. Keeping these areas separate helps distinguish a promising tool from a proven treatment claim.

Pelvic floor muscle training for stress incontinence: strong evidence

This is the foundation of the evidence, and it concerns the exercise rather than biofeedback specifically. A Cochrane review found PFMT more effective than no treatment for urinary incontinence in women. Its abridged publication described 31 randomized controlled trials involving 1,817 women and supported PFMT as a first-line conservative treatment. Many participants were adult women with stress incontinence. Programs differed, and follow-up was often relatively short. The findings support training as a treatment without identifying one optimal routine for everyone. Cochrane review · Abridged review · Adherence review

What biofeedback adds to guided exercise

The 2025 Cochrane review included 41 studies and 3,483 women. It found high-certainty evidence of little or no additional benefit for incontinence-related quality of life. A small additional reduction in daily leakage episodes was probably not clinically important; certainty for that finding was moderate. An earlier review likewise did not establish clear differences between training methods. Favorable findings in small early studies do not outweigh the larger evidence base. The newer review excluded pregnant women and those less than six months postpartum, so its conclusions should not be transferred directly to those groups. 2022 review · Early trial · Cochrane 2025

Training after childbirth: benefits with important limits

Results depend partly on whether the goal is to prevent symptoms or treat existing incontinence. An older Cochrane analysis mainly supported preventive exercise during pregnancy; evidence for broadly offered postpartum programs was less clear. A nonrandomized follow-up found lasting continence benefits, while a randomized trial found less leakage with an exercise program during pregnancy. Neither finding establishes the safety of a vaginal device during pregnancy.

A 2025 meta-analysis found moderate-certainty evidence of lower odds of urinary incontinence and pelvic organ prolapse with postpartum PFMT. The favorable findings for separation of the abdominal muscles, or diastasis recti, concerned abdominal exercise rather than PFMT and had lower certainty. Follow-up study · Pregnancy trial · Earlier Cochrane review · 2025 meta-analysis

Results specific to Perifit: limited evidence

The 2024 analysis included 6,060 Perifit users who voluntarily completed symptom questionnaires before and during training. Reported symptoms improved over time. There was no control group, however, and users who stopped early or did not provide a follow-up questionnaire were not represented. The analysis cannot isolate the device’s effect or provide a success rate for everyone who buys it. Both authors were manufacturer employees.

A study of the EMY trainer also lacked a control group. In a small randomized trial of the Vibrance device, symptoms initially improved faster, but final incontinence scores and self-reported cure rates did not differ significantly between groups. These studies are useful early evidence, with different limitations and different devices. Vibrance · EMY · Perifit

Sexual well-being: limited evidence

A 2024 meta-analysis found improvements in several aspects of sexual function. Large differences between studies and exercise programs meant that certainty was very low. This leaves room for a possible benefit of pelvic floor training, but it is not evidence specific to Perifit or a guarantee of a particular sexual outcome. Meta-analysis

Uses supported by the research

Guided pelvic floor exercise is well supported for stress and mixed urinary incontinence. A device can be a personal exercise aid within that plan. Its usefulness depends on the cause of the leakage and whether you can contract and relax the relevant muscles appropriately.

Stress incontinence in adult women. PFMT can improve symptoms compared with no treatment. The average additional benefit of biofeedback is smaller. In daily life, fewer leaks and fewer restrictions matter more than a higher game score. PFMT review · Biofeedback review

Recovery after childbirth. An appropriately guided program can support recovery. When a vaginal device becomes suitable depends on healing and symptoms. Evidence for exercise in general does not automatically establish that it is appropriate to insert a probe early in recovery. Postpartum exercise review

Help with a regular routine. If you know which exercises are appropriate but find consistency difficult, an app may help you practice. The available adherence review does not establish that game-based feedback reliably produces better adherence than other approaches. Adherence review

Symptoms that need assessment first. Pelvic pressure, a sensation of something descending, pain, or difficulty emptying the bladder can have different causes. When muscles are overly tense, treatment emphasizes relaxation; adding strengthening exercises may worsen symptoms. An expert consensus recommends pelvic floor physical therapy as first-line treatment for high-tone dysfunction. Expert consensus

Building a plan around the evidence

A training plan should match the clinical assessment. For stress or mixed incontinence, NICE recommends supervised PFMT for at least three months, including at least eight contractions three times a day. This recommendation concerns the overall exercise program, not a Perifit session schedule. Routine biofeedback is not required for every program. NICE guideline

• Record a starting point. Note leakage, urgency, and the situations in which symptoms occur. A validated questionnaire such as the ICIQ-UI SF can help you compare symptoms later.
• Agree on an appropriate amount of exercise. Learn both the contraction and full relaxation. Follow the instructions for your particular device; more repetitions do not necessarily mean better results.
• Plan a follow-up. Review whether you can perform the exercises and whether symptoms are improving. If progress stalls, reassess technique and diagnosis rather than simply increasing intensity.
• Watch the pattern over time. A brief diary can help distinguish day-to-day variation from a lasting change. Urgency alone does not prove that the pelvic floor is too tense; it has other possible causes.
• Reassess symptoms. Use the same questionnaire and comparable everyday situations. Pause device use and seek assessment for new pain, bleeding, signs of infection, or worsening symptoms.

Who may benefit and who should avoid unsupervised use

A device is more likely to be appropriate when strengthening fits your diagnosis and you can exercise without pain. It should make a suitable routine easier, not provoke symptoms.

After childbirth or surgery, individual healing matters. General advice to do pelvic floor exercises is not equivalent to clearance to use an internal probe.

Do not start using the device on your own in the following situations:

• Pelvic organ prolapse. Significant prolapse or unexplained symptoms need assessment first. A trainer does not replace choosing an appropriate treatment.
• Significant pelvic pain. Clinical assessment comes first; do not use a vaginal device on your own to work through pain.
• Recent pelvic surgery. Obtain clearance from the clinician responsible for your recovery.
• An active vaginal infection. Defer use until it has been assessed and addressed.
• An overly tense pelvic floor. Treatment may need to focus on relaxation, making a conventional strengthening routine unsuitable.
• Pregnancy and early postpartum recovery. The manufacturer advises against use during pregnancy and in the first six weeks after birth. Its pregnancy FAQ describes returning around six to eight weeks after delivery, with professional clearance. Timing depends on recovery, not the calendar alone. Manufacturer guidance

Unexplained vaginal bleeding, blood in the urine, difficulty urinating, neurological symptoms, or a silicone allergy also need assessment before use. Consult the complete contraindications for your model. Manufacturer guidance

Safety and what FDA clearance means

For medical devices, “FDA-cleared” and “FDA-approved” are different regulatory terms. The distinction matters when interpreting packaging or advertising.

The FDA cleared Perifit through the 510(k) pathway on February 10, 2023, under K221476. The listed indications are stress, mild-to-moderate urge, and mixed urinary incontinence in adult women. Clearance rests on substantial equivalence to a predicate device. It is more than company registration, but it does not verify every broader wellness benefit. FDA decision and indications

Safety also depends on day-to-day use. Clean and store the vaginal sensor according to the manufacturer’s instructions. Poor hygiene can create an infection risk. New or unusual discharge, odor, or pain calls for a pause and clinical assessment, rather than continuing through symptoms.

High-tone pelvic floor dysfunction deserves particular attention. If the muscles are already overly tense, repeated strengthening can aggravate symptoms. Treatment may instead emphasize “down-training”: learning to release tension and relax. A pelvic floor physical therapist can assess whether this approach is appropriate and tailor it to the problem.

The 2024 Cochrane review comparing exercise methods, doses, and supervision models found uncertainty around many details. Reported adverse effects often involved vaginal or rectal devices, including discharge, spotting, or discomfort. This is a reason to pay attention to symptoms and exercise selection, not a reason to assume that every device or routine carries the same risk. Cochrane review

Which measurements show whether training is helping

The most useful outcomes are your symptoms and what becomes easier in daily life.

A blood test cannot measure the success of pelvic floor training. The sensor display gives feedback during an exercise, while questionnaires such as the ICIQ-UI SF or UDI-6 capture leakage and its burden. For sexual function, clinicians may use instruments such as the FSFI or PISQ-IR. Even standardized questionnaires rely on self-report; they do not directly measure muscle force.

A professional assessment can help identify whether strength, coordination, relaxation, or another problem needs attention. It may include a vaginal examination when relevant and with your consent. Its length and scope depend on the clinical question; one fixed examination format is not required for every treatment.

Compare symptoms before and during training. If an app score rises but everyday function does not improve, the score alone does not show that treatment has achieved its purpose.

Making sense of a follow-up symptom score

Repeating the same questionnaire makes comparison easier. It can show change, but cannot by itself establish that the device caused it.

Useful observations include whether leaks become less frequent, urgency becomes easier to manage, or activities become less restricted. A subjective sense of improved muscle tone can also be recorded, but it is not a direct measurement. None of these observations establishes that a device outperforms unaided exercise. Expectations about a program that takes time and money can influence perceived improvement.

Standardized questionnaires complement those observations. Compare similar time periods and consider whether the change matters in your daily life. Successful treatment does not require every numerical measure to rise.

One frequently cited study identified a four-point reduction in ICIQ-UI SF as clinically meaningful after nonsurgical treatment, assessed at one year. This is not a universal cutoff. A later study of app-supported self-management found that meaningful change varied with initial symptom severity. The same number should not simply be applied to a different instrument such as UDI-6. Interpret the pattern alongside your actual symptoms. Earlier threshold study · Baseline severity and treatment context

When Perifit is not the right next step

Symptoms suggesting prolapse, excessive muscle tension, or substantial pain call for pelvic floor physical therapy or gynecologic assessment before a device purchase.

The same applies after recent pelvic surgery, during postpartum recovery without clearance, or when symptoms suggest a problem beyond mild stress leakage. Significant or persistent pelvic pain and suspected pelvic floor dysfunction need a diagnosis and an appropriate treatment plan. A consumer app cannot replace either a physical therapy assessment or a gynecologic examination.

Perifit may support a suitable plan once the problem is understood. It is not the right approach to every pelvic floor complaint, and a device is only useful if the exercise it encourages fits your needs.

Frequently asked questions

Does Perifit actually work?

Pelvic floor exercise is supported by good evidence for urinary incontinence. Adding biofeedback produces little or no meaningful average improvement in incontinence-related quality of life compared with PFMT alone, according to the Cochrane review. Those are separate findings: the exercise can help even when the device’s additional contribution is limited. PFMT review · Biofeedback review

Is Perifit FDA-approved?

Perifit has 510(k) clearance under K221476 for specified urinary incontinence treatment in adult women. The accurate term is FDA-cleared. This status does not establish every additional wellness claim. FDA documents

How often should you use Perifit?

Frequency should follow your device’s instructions and your individual plan. The manufacturer’s training guidance suggests starting with three to five ten-minute sessions per week. Treat that as product guidance, not a universally optimal clinical prescription. Check the current instructions for your model and avoid increasing training through pain or fatigue. General PFMT recommendations should not automatically become a schedule for probe use. Manufacturer FAQ · Training instructions

Who should not use Perifit?

Avoid use during pregnancy, early postpartum recovery, or with infection symptoms, unexplained bleeding, or significant pain. An overly tense pelvic floor needs a different approach. After surgery or with prolapse, obtain professional assessment first. Contraindications

What does research say about Perifit?

Perifit provides biofeedback during pelvic floor exercises. The evidence for exercise in women with urinary incontinence includes 31 randomized trials with 1,817 participants. Biofeedback’s additional benefit varies by outcome: there is little difference in incontinence-related quality of life, while satisfaction may improve. The Perifit observational study did not include a comparison group training without the device. PFMT review · Biofeedback review

Is Perifit better than Kegel exercises alone?

Biofeedback overall has not shown a clear additional benefit for incontinence-related quality of life. If the app helps you practice, it can still be useful to you. Available Perifit data do not establish superiority over well-guided training without a device. Biofeedback review · Perifit study

How can I tell whether Perifit is helping me?

Look for fewer leaks, fewer restrictions, and an understandable change on the same symptom questionnaire over time. The force display supports practice but does not replace these outcomes. If symptoms persist or worsen, have the plan and diagnosis reassessed.

Is Perifit safe during pregnancy or after childbirth?

The manufacturer advises against use during pregnancy. After childbirth, wait until the early healing period has passed and a healthcare professional has cleared you to use the probe. Exercises without a device may be appropriate on a different timetable; ask for guidance that fits your recovery. Manufacturer guidance

Sources and references

• Newman DK (2014). Pelvic floor muscle rehabilitation using biofeedback. Urologic nursing, 34(4), 193-202. https://pubmed.ncbi.nlm.nih.gov/25233622/

• Dumoulin C, Cacciari LP, Hay-Smith EJC (2018). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. The Cochrane database of systematic reviews, 10(10), CD005654. https://doi.org/10.1002/14651858.CD005654.pub4

• Villa-Del-Pino I, Jiménez-Rejano JJ, Rebollo-Salas M, Rodríguez-Domínguez, Á. J., Suárez-Serrano CM (2025). Compliance and Adherence to Pelvic Floor Exercise Therapy in People with Pelvic Floor Disorders: A Systematic Review and Meta-Analysis. Life (Basel, Switzerland), 15(4). https://doi.org/10.3390/life15040613

• Burgio KL, Robinson JC, Engel BT (1986). The role of biofeedback in Kegel exercise training for stress urinary incontinence. American journal of obstetrics and gynecology, 154(1), 58-64. https://doi.org/10.1016/0002-9378(86)90393-5

• Fernandes ACN, Jorge CH, Weatherall M, Ribeiro IV, Wallace SA, Hay-Smith EJC (2025). Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women. The Cochrane database of systematic reviews, 3(3), CD009252. https://doi.org/10.1002/14651858.CD009252.pub2

• Cacciari LP, Dumoulin C, Hay-Smith EJ (2019). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a cochrane systematic review abridged republication. Brazilian journal of physical therapy, 23(2), 93-107. https://doi.org/10.1016/j.bjpt.2019.01.002

• Alouini S, Memic S, Couillandre A (2022). Pelvic Floor Muscle Training for Urinary Incontinence with or without Biofeedback or Electrostimulation in Women: A Systematic Review. International journal of environmental research and public health, 19(5). https://doi.org/10.3390/ijerph19052789

• Boyle R, Hay-Smith EJ, Cody JD, Mørkved S (2014). Pelvic floor muscle training for prevention and treatment of urinary and fecal incontinence in antenatal and postnatal women: a short version Cochrane review. Neurourology and urodynamics, 33(3), 269-76. https://doi.org/10.1002/nau.22402

• Stafne SN, Salvesen, K. Å., Romundstad PR, Torjusen IH, Mørkved S (2012). Does regular exercise including pelvic floor muscle training prevent urinary and anal incontinence during pregnancy? A randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology, 119(10), 1270-80. https://doi.org/10.1111/j.1471-0528.2012.03426.x

• Mørkved S, Bø K (2000). Effect of postpartum pelvic floor muscle training in prevention and treatment of urinary incontinence: a one-year follow up. BJOG : an international journal of obstetrics and gynaecology, 107(8), 1022-8. https://doi.org/10.1111/j.1471-0528.2000.tb10407.x

• Beamish NF, Davenport MH, Ali MU, Gervais MJ, Sjwed TN, Bains G, Sivak A, Deering RE, Ruchat SM (2025). Impact of postpartum exercise on pelvic floor disorders and diastasis recti abdominis: a systematic review and meta-analysis. British journal of sports medicine, 59(8), 562-575. https://doi.org/10.1136/bjsports-2024-108619

• Perrier ET, Aumont L (2024). Pelvic Floor Muscle Training Using the Perifit Device for the Treatment of Urinary Incontinence: A Pragmatic Trial Using Real-World Data. Women’s health reports (New Rochelle, N.Y.), 5(1), 250-258. https://doi.org/10.1089/whr.2023.0172

• Jochum F, Garbin O, Godet J, Ragueneau M, Meyer C, Billecocq S, Lecointre L, Akladios C, Host A (2022). Prospective evaluation of the connected biofeedback EMY Kegel trainer in the management of stress urinary incontinence. Journal of gynecology obstetrics and human reproduction, 51(2), 102280. https://doi.org/10.1016/j.jogoh.2021.102280

• Ong TA, Khong SY, Ng KL, Ting JR, Kamal N, Yeoh WS, Yap NY, Razack AH (2015). Using the Vibrance Kegel Device With Pelvic Floor Muscle Exercise for Stress Urinary Incontinence: A Randomized Controlled Pilot Study. Urology, 86(3), 487-91. https://doi.org/10.1016/j.urology.2015.06.022

• Jorge CH, Bø K, Chiazuto Catai C, Oliveira Brito LG, Driusso P, Kolberg Tennfjord M (2024). Pelvic floor muscle training as treatment for female sexual dysfunction: a systematic review and meta-analysis. American journal of obstetrics and gynecology, 231(1), 51-66.e1. https://doi.org/10.1016/j.ajog.2024.01.001

• Hay-Smith EJC, Starzec-Proserpio M, Moller B, Aldabe D, Cacciari L, Pitangui ACR, Vesentini G, Woodley SJ, Dumoulin C, Frawley HC, Jorge CH, Morin M, Wallace SA, Weatherall M (2024). Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. The Cochrane database of systematic reviews, 12(12), CD009508. https://doi.org/10.1002/14651858.CD009508.pub2

• FDA (2023). Perifit, 510(k) K221476: decision, indications, and device description. https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221476.pdf

• NICE. Urinary incontinence and pelvic organ prolapse in women: management (NG123), pelvic floor training recommendations. https://www.nice.org.uk/guidance/ng123/chapter/recommendations

• Perifit. Frequently Asked Questions: use and contraindications. Manufacturer information, accessed October 31, 2026. https://perifit.co/pages/faq-perifit

• Torosis M et al. (2024). A Treatment Algorithm for High-Tone Pelvic Floor Dysfunction. https://pmc.ncbi.nlm.nih.gov/articles/PMC10953682/

• The Minimum Clinically Important Difference of the International Consultation on Incontinence Questionnaires (ICIQ-UI SF and ICIQ-LUTSqol) (2019). https://pubmed.ncbi.nlm.nih.gov/31415780/

• Minimum important difference of the ICIQ-UI SF score after self-management of urinary incontinence (2024). https://pubmed.ncbi.nlm.nih.gov/38355503/

• Perifit. How to Use a Pelvic Floor Trainer? Manufacturer training instructions. https://perifit.co/blogs/pelvic-floor/how-to-use-a-pelvic-floor-trainer